Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K
REVENUE     
OPERATING EXPENSES     
General and administrative  6.09.10.5
Research and development  3.33.40.4
Gain on waiver of common stock issuable  -1.5  
    Total operating expenses  17.112.42.1
LOSS FROM OPERATIONS  -7.8-12.4-1.0
   
OTHER INCOME     
Interest income  0.1  
    Total other income  0.1 0.1
    NET LOSS  -7.7-12.4-0.8
   
Net loss per common share - basic and diluted  ($0.75)($1.43)($0.13)
   
Weighted average number of common shares outstanding - basic and diluted  10.38.76.6
   
COMPREHENSIVE LOSS     
Net loss  -7.7-12.4-0.8
Other comprehensive loss - loss on foreign currency translation  0.00.0 
    Total comprehensive loss  -7.7-12.5-0.8

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy